Patents by Inventor Gunilla Huledal

Gunilla Huledal has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • PDAC TREATMENT REGIMEN
    Publication number: 20230085602
    Abstract: The human Interleukin 1 Receptor antagonist anakinra can be used in the treatment of pancreatic ductal adenocarcinoma (PDAC). The treatment involves administration of a daily dose of approximately at least 200 mg of anakinra to a patient in need thereof, for example to a patient who is undergoing a chemotherapy treatment regimen. The anakinra can be used in related treatment methods and corresponding pharmaceutical compositions.
    Type: Application
    Filed: February 4, 2021
    Publication date: March 16, 2023
    Applicant: Swedish Orphan Biovitrum AB (publ )
    Inventors: Bent Winding, Christina Kaiser, Gunilla Huledal